Indero

Indero is a specialized, dual-focus Contract Research Organization (CRO) that provides comprehensive clinical research services for the dermatology and rheumatology sectors. Formerly known as Innovaderm Research, the company rebranded in 2025 to reflect its expanded expertise in immune-mediated inflammatory diseases. Indero offers end-to-end support for clinical trials, ranging from protocol design and patient recruitment via its proprietary Clinago platform to advanced biometrics and regulatory consulting. The firm is distinguished by its deep scientific foundation, having pioneered innovative methodologies such as quantitative gene expression analysis for rapid early-phase drug evaluation. Headquartered in Montreal, Indero operates globally with a presence in over 30 countries across North America, Europe, Latin America, and the Asia-Pacific region.